Home ➤ Life Science ➤ Biotechnology ➤ Cancer Gene Therapy Market
Cancer Gene Therapy Market
Published date: Dec 2024 • Formats:
Request Sample Schedule a Call

Global Cancer Gene Therapy Market Analysis By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer), By Indication (Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Others), By End Use (Biopharmaceutical Companies, Research Institutes, Diagnostic Centers, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

  • Published date: Dec 2024
  • Report ID: 136368
  • Number of Pages: 258
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Cancer Gene Therapy Market Trends
      • 2.3. Regulatory Framework
      • 2.4. Opportunity Map Analysis
      • 2.5. Opportunity Orbits
      • 2.6. PESTLE Analysis
      • 2.7. PORTER’S Five Force Analysis
      • 2.8. Drivers & Restraints Impact Analysis
      • 2.9. Value Chain Analysis
        • 2.9.1. List of Raw Materials Suppliers
        • 2.9.2. List of Cancer Gene Therapy Manufacturers
        • 2.9.3. List of Dealer/Distributors
      • 2.10. Regional Market Share and BPS Analysis
      • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Cancer Gene Therapy Market Analysis and Forecast, By Segment, 2019-2033
      • 3.1. Key Findings
      • 3.2. Global Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
      • 3.3. Global Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
        • 3.3.1. Gene Induced Immunotherapy
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Oncolytic Virotherapy
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Gene Transfer
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
      • 3.4. Global Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 3.5. Global Cancer Gene Therapy Market Attractiveness Analysis, By Indication
        • 3.5.1. Breast Cancer
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Ovarian Cancer
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Pancreatic Cancer
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Others
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
      • 3.6. Global Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 3.7. Global Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
        • 3.7.1. Biopharmaceutical Companies
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Research Institutes
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Diagnostic Centers
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Others
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
    • 4. Global Cancer Gene Therapy Market Analysis and Forecast, By Region, 2019-2033
      • 4.1. Key Findings
      • 4.2. Global Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Cancer Gene Therapy Market Attractiveness Analysis, By Region
    • 5. North America Cancer Gene Therapy Market Analysis and Forecast, 2019-2033
      • 5.1. Key Findings
      • 5.2. North America Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
      • 5.3. North America Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • 5.4. North America Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 5.5. North America Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • 5.6. North America Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 5.7. North America Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • 5.8. North America Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 5.9. North America Cancer Gene Therapy Market Attractiveness Analysis, By Country
        • 5.9.1. The US
        • 5.9.2. Canada
    • 6. Europe Cancer Gene Therapy Market Analysis and Forecast, 2019-2033
      • 6.1. Key Findings
      • 6.2. Europe Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
      • 6.3. Europe Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • 6.4. Europe Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 6.5. Europe Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • 6.6. Europe Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 6.7. Europe Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • 6.8. Europe Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 6.9. Europe Cancer Gene Therapy Market Attractiveness Analysis, By Country
        • 6.9.1. Germany
        • 6.9.2. The UK
        • 6.9.3. France
        • 6.9.4. Spain
        • 6.9.5. Italy
        • 6.9.6. Russia
        • 6.9.7. Netherland
        • 6.9.8. Rest of Europe
    • 7. Asia Pacific Cancer Gene Therapy Market Analysis and Forecast, 2019-2033
      • 7.1. Key Findings
      • 7.2. Asia Pacific Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
      • 7.3. Asia Pacific Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • 7.4. Asia Pacific Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 7.5. Asia Pacific Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • 7.6. Asia Pacific Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 7.7. Asia Pacific Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • 7.8. Asia Pacific Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 7.9. Asia Pacific Cancer Gene Therapy Market Attractiveness Analysis, By Country
        • 7.9.1. China
        • 7.9.2. Japan
        • 7.9.3. South Korea
        • 7.9.4. India
        • 7.9.5. Australia
        • 7.9.6. New Zealand
        • 7.9.7. Singapore
        • 7.9.8. Thailand
        • 7.9.9. Vietnam
        • 7.9.10. Rest of Asia Pacific
    • 8. Latin America Cancer Gene Therapy Market Analysis and Forecast, 2019-2033
      • 8.1. Key Findings
      • 8.2. Latin America Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
      • 8.3. Latin America Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • 8.4. Latin America Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 8.5. Latin America Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • 8.6. Latin America Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 8.7. Latin America Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • 8.8. Latin America Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 8.9. Latin America Cancer Gene Therapy Market Attractiveness Analysis, By Country
        • 8.9.1. Brazil
        • 8.9.2. Mexico
        • 8.9.3. Rest of Latin America
    • 9. Middle East & Africa Cancer Gene Therapy Market Analysis and Forecast, 2019-2033
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy, 2019-2033
      • 9.3. Middle East & Africa Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • 9.4. Middle East & Africa Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 9.5. Middle East & Africa Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • 9.6. Middle East & Africa Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 9.7. Middle East & Africa Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • 9.8. Middle East & Africa Cancer Gene Therapy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 9.9. Middle East & Africa Cancer Gene Therapy Market Attractiveness Analysis, By Country
        • 9.9.1. South Africa
        • 9.9.2. Saudi Arabia
        • 9.9.3. UAE
        • 9.9.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. CRISPR Therapeutics
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Pfizer Inc.
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. GSK plc
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Merck KGaA
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Novartis AG
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. AstraZeneca
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Atara Biotherapeutics, Inc.
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Adaptimmune
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. American Gene Technologies
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. Genelux Corporation
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
        • 10.7.11. ImmunoACT
          • 10.7.11.1. Company Details
          • 10.7.11.2. Business Overview
          • 10.7.11.3. Product Portfolio
          • 10.7.11.4. Financial Insights
          • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.11.6. SWOT Analysis
          • 10.7.11.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 2. Global Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 3. Global Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 4. Global Cancer Gene Therapy Market Value (US$ Mn), By Region, 2019-2033
      • Table 5. North America Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 6. North America Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 7. North America Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 8. North America Cancer Gene Therapy Market Value (US$ Mn), By Country, 2019-2033
      • Table 9. The US Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 10. The US Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 11. The US Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 12. Canada Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 13. Canada Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 14. Canada Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 15. Europe Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 16. Europe Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 17. Europe Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 18. Europe Cancer Gene Therapy Market Value (US$ Mn), By Country, 2019-2033
      • Table 19. Germany Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 20. Germany Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 21. Germany Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 22. The UK Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 23. The UK Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 24. The UK Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 25. France Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 26. France Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 27. France Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 28. Spain Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 29. Spain Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 30. Spain Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 31. Italy Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 32. Italy Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 33. Italy Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 34. Russia Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 35. Russia Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 36. Russia Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 37. Netherland Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 38. Netherland Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 39. Netherland Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 40. Rest of Europe Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 41. Rest of Europe Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 42. Rest of Europe Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 43. Asia Pacific Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 44. Asia Pacific Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 45. Asia Pacific Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 46. Asia Pacific Cancer Gene Therapy Market Value (US$ Mn), By Country, 2019-2033
      • Table 47. China Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 48. China Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 49. China Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 50. India Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 51. India Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 52. India Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 53. Japan Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 54. Japan Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 55. Japan Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 56. South Korea Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 57. South Korea Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 58. South Korea Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 59. Australia Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 60. Australia Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 61. Australia Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 62. New Zealand Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 63. New Zealand Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 64. New Zealand Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 65. Singapore Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 66. Singapore Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 67. Singapore Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 68. Thailand Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 69. Thailand Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 70. Thailand Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 71. Vietnam Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 72. Vietnam Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 73. Vietnam Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 74. Rest of Asia Pacific Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 75. Rest of Asia Pacific Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 76. Rest of Asia Pacific Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 77. Latin America Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 78. Latin America Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 79. Latin America Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 80. Latin America Cancer Gene Therapy Market Value (US$ Mn), By Country, 2019-2033
      • Table 81. Brazil Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 82. Brazil Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 83. Brazil Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 84. Mexico Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 85. Mexico Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 86. Mexico Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 87. Rest of Latin America Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 88. Rest of Latin America Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 89. Rest of Latin America Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 90. Middle East & Africa Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 91. Middle East & Africa Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 92. Middle East & Africa Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 93. Middle East & Africa Cancer Gene Therapy Market Value (US$ Mn), By Country, 2019-2033
      • Table 94. South Africa Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 95. South Africa Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 96. South Africa Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 97. Saudi Arabia Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 98. Saudi Arabia Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 99. Saudi Arabia Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 100. UAE Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 101. UAE Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 102. UAE Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 103. Rest of Middle East & Africa Cancer Gene Therapy Market Value (US$ Mn), By Therapy, 2019-2033
      • Table 104. Rest of Middle East & Africa Cancer Gene Therapy Market Value (US$ Mn), By Indication, 2019-2033
      • Table 105. Rest of Middle East & Africa Cancer Gene Therapy Market Value (US$ Mn), By Distribution Channel, 2019-2033
    • List of Figures
      • Figure 1. Global Cancer Gene Therapy Market Snapshot: Market Value (US$ Mn), 2019-2033
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Cancer Gene Therapy Market
      • Figure 5. Global Cancer Gene Therapy Market Analysis, By Therapy, 2019, 2023 and 2033
      • Figure 6. Global Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • Figure 7. Global Cancer Gene Therapy Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 8. Global Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • Figure 9. Global Cancer Gene Therapy Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 10. Global Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • Figure 11. Global Cancer Gene Therapy Market Analysis, By Region, 2019, 2023 and 2033
      • Figure 12. Global Cancer Gene Therapy Market Attractiveness Analysis, By Region
      • Figure 13. North America Cancer Gene Therapy Market Analysis, By Therapy, 2019, 2023 and 2033
      • Figure 14. North America Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • Figure 15. North America Cancer Gene Therapy Market (US$ Mn), by Gene Induced Immunotherapy, 2019-2033
      • Figure 16. North America Cancer Gene Therapy Market (US$ Mn), by Oncolytic Virotherapy, 2019-2033
      • Figure 17. North America Cancer Gene Therapy Market (US$ Mn), by Gene Transfer, 2019-2033
      • Figure 18. North America Cancer Gene Therapy Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 19. North America Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • Figure 20. North America Cancer Gene Therapy Market (US$ Mn), by Breast Cancer, 2019-2033
      • Figure 21. North America Cancer Gene Therapy Market (US$ Mn), by Ovarian Cancer, 2019-2033
      • Figure 22. North America Cancer Gene Therapy Market (US$ Mn), by Pancreatic Cancer, 2019-2033
      • Figure 23. North America Cancer Gene Therapy Market (US$ Mn), by Others, 2019-2033
      • Figure 24. North America Cancer Gene Therapy Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 25. North America Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • Figure 26. North America Cancer Gene Therapy Market (US$ Mn), by Biopharmaceutical Companies, 2019-2033
      • Figure 27. North America Cancer Gene Therapy Market (US$ Mn), by Research Institutes, 2019-2033
      • Figure 28. North America Cancer Gene Therapy Market (US$ Mn), by Diagnostic Centers, 2019-2033
      • Figure 29. North America Cancer Gene Therapy Market (US$ Mn), by Others, 2019-2033
      • Figure 30. North America Cancer Gene Therapy Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 31. North America Cancer Gene Therapy Market Attractiveness Analysis, By Country
      • Figure 32. Europe Cancer Gene Therapy Market Analysis, By Therapy, 2019, 2023 and 2033
      • Figure 33. Europe Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • Figure 34. Europe Cancer Gene Therapy Market (US$ Mn), by Gene Induced Immunotherapy, 2019-2033
      • Figure 35. Europe Cancer Gene Therapy Market (US$ Mn), by Oncolytic Virotherapy, 2019-2033
      • Figure 36. Europe Cancer Gene Therapy Market (US$ Mn), by Gene Transfer, 2019-2033
      • Figure 37. Europe Cancer Gene Therapy Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 38. Europe Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • Figure 39. Europe Cancer Gene Therapy Market (US$ Mn), by Breast Cancer, 2019-2033
      • Figure 40. Europe Cancer Gene Therapy Market (US$ Mn), by Ovarian Cancer, 2019-2033
      • Figure 41. Europe Cancer Gene Therapy Market (US$ Mn), by Pancreatic Cancer, 2019-2033
      • Figure 42. Europe Cancer Gene Therapy Market (US$ Mn), by Others, 2019-2033
      • Figure 43. Europe Cancer Gene Therapy Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 44. Europe Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • Figure 45. Europe Cancer Gene Therapy Market (US$ Mn), by Biopharmaceutical Companies, 2019-2033
      • Figure 46. Europe Cancer Gene Therapy Market (US$ Mn), by Research Institutes, 2019-2033
      • Figure 47. Europe Cancer Gene Therapy Market (US$ Mn), by Diagnostic Centers, 2019-2033
      • Figure 48. Europe Cancer Gene Therapy Market (US$ Mn), by Others, 2019-2033
      • Figure 49. Europe Cancer Gene Therapy Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 50. Europe Cancer Gene Therapy Market Attractiveness Analysis, By Country
      • Figure 51. Asia Pacific Cancer Gene Therapy Market Analysis, By Therapy, 2019, 2023 and 2033
      • Figure 52. Asia Pacific Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • Figure 53. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Gene Induced Immunotherapy, 2019-2033
      • Figure 54. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Oncolytic Virotherapy, 2019-2033
      • Figure 55. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Gene Transfer, 2019-2033
      • Figure 56. Asia Pacific Cancer Gene Therapy Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 57. Asia Pacific Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • Figure 58. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Breast Cancer, 2019-2033
      • Figure 59. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Ovarian Cancer, 2019-2033
      • Figure 60. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Pancreatic Cancer, 2019-2033
      • Figure 61. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Others, 2019-2033
      • Figure 62. Asia Pacific Cancer Gene Therapy Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 63. Asia Pacific Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • Figure 64. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Biopharmaceutical Companies, 2019-2033
      • Figure 65. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Research Institutes, 2019-2033
      • Figure 66. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Diagnostic Centers, 2019-2033
      • Figure 67. Asia Pacific Cancer Gene Therapy Market (US$ Mn), by Others, 2019-2033
      • Figure 68. Asia Pacific Cancer Gene Therapy Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 69. Asia Pacific Cancer Gene Therapy Market Attractiveness Analysis, By Country
      • Figure 70. Latin America Cancer Gene Therapy Market Analysis, By Therapy, 2019, 2023 and 2033
      • Figure 71. Latin America Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • Figure 72. Latin America Cancer Gene Therapy Market (US$ Mn), by Gene Induced Immunotherapy, 2019-2033
      • Figure 73. Latin America Cancer Gene Therapy Market (US$ Mn), by Oncolytic Virotherapy, 2019-2033
      • Figure 74. Latin America Cancer Gene Therapy Market (US$ Mn), by Gene Transfer, 2019-2033
      • Figure 75. Latin America Cancer Gene Therapy Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 76. Latin America Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • Figure 77. Latin America Cancer Gene Therapy Market (US$ Mn), by Breast Cancer, 2019-2033
      • Figure 78. Latin America Cancer Gene Therapy Market (US$ Mn), by Ovarian Cancer, 2019-2033
      • Figure 79. Latin America Cancer Gene Therapy Market (US$ Mn), by Pancreatic Cancer, 2019-2033
      • Figure 80. Latin America Cancer Gene Therapy Market (US$ Mn), by Others, 2019-2033
      • Figure 81. Latin America Cancer Gene Therapy Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 82. Latin America Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • Figure 83. Latin America Cancer Gene Therapy Market (US$ Mn), by Biopharmaceutical Companies, 2019-2033
      • Figure 84. Latin America Cancer Gene Therapy Market (US$ Mn), by Research Institutes, 2019-2033
      • Figure 85. Latin America Cancer Gene Therapy Market (US$ Mn), by Diagnostic Centers, 2019-2033
      • Figure 86. Latin America Cancer Gene Therapy Market (US$ Mn), by Others, 2019-2033
      • Figure 87. Latin America Cancer Gene Therapy Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 88. Latin America Cancer Gene Therapy Market Attractiveness Analysis, By Country
      • Figure 89. Middle East & Africa Cancer Gene Therapy Market Analysis, By Therapy, 2019, 2023 and 2033
      • Figure 90. Middle East & Africa Cancer Gene Therapy Market Attractiveness Analysis, By Therapy
      • Figure 91. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Gene Induced Immunotherapy, 2019-2033
      • Figure 92. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Oncolytic Virotherapy, 2019-2033
      • Figure 93. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Gene Transfer, 2019-2033
      • Figure 94. Middle East & Africa Cancer Gene Therapy Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 95. Middle East & Africa Cancer Gene Therapy Market Attractiveness Analysis, By Indication
      • Figure 96. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Breast Cancer, 2019-2033
      • Figure 97. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Ovarian Cancer, 2019-2033
      • Figure 98. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Pancreatic Cancer, 2019-2033
      • Figure 99. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Others, 2019-2033
      • Figure 100. Middle East & Africa Cancer Gene Therapy Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 101. Middle East & Africa Cancer Gene Therapy Market Attractiveness Analysis, By Distribution Channel
      • Figure 102. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Biopharmaceutical Companies, 2019-2033
      • Figure 103. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Research Institutes, 2019-2033
      • Figure 104. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Diagnostic Centers, 2019-2033
      • Figure 105. Middle East & Africa Cancer Gene Therapy Market (US$ Mn), by Others, 2019-2033
      • Figure 106. Middle East & Africa Cancer Gene Therapy Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 107. Middle East & Africa Cancer Gene Therapy Market Attractiveness Analysis, By Country
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Cancer Gene Therapy Market
  • 136368
  • Dec 2024
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options